| Literature DB >> 35228808 |
Tadesse Shume1, Tewodros Tesfa1, Shambel Mekonnen1, Haftu Asmerom1, Fikru Tebeje1, Fitsum Weldegebreal1.
Abstract
BACKGROUND: Infections of sterile body fluids are susceptible to serious invasive bacterial infections and critical, with high morbidity and sequelae risk. This study has not been conducted previously in eastern Ethiopia.Entities:
Keywords: Eastern Ethiopia; antimicrobial resistance; bacteria; sterile body fluids
Year: 2022 PMID: 35228808 PMCID: PMC8882023 DOI: 10.2147/IDR.S351961
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Socio-Demographic Character of the Study Participants of Sterile Body Fluid Infections at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021
| Variables | Category | Frequency | % |
|---|---|---|---|
| ≤20 | 96 | 47.1 | |
| 21–40 | 16 | 7.8 | |
| 41–60 | 35 | 17.2 | |
| ≥61 | 57 | 27.9 | |
| Male | 130 | 63.7 | |
| Female | 74 | 36.3 | |
| Urban | 69 | 33.8 | |
| Rural | 135 | 66.2 | |
| Under age* | 77 | 37.7 | |
| Single | 29 | 22.8 | |
| Married | 81 | 63.8 | |
| Widowed | 5 | 4.0 | |
| Divorced | 12 | 9.4 | |
| Pre-school | 62 | 30.4 | |
| Unable to read and write | 66 | 32.4 | |
| Read and write | 19 | 9.3 | |
| Primary | 23 | 11.3 | |
| Secondary/High school | 16 | 7.8 | |
| College and above | 18 | 8.8 | |
| Government employee | 43 | 21.1 | |
| Labor worker | 2 | 1.0 | |
| Student | 37 | 18.1 | |
| House wife | 8 | 3.9 | |
| Farmer | 80 | 39.2 | |
| Merchant | 26 | 12.7 | |
| Other | 8 | 3.9 | |
| ≤1500 | 110 | 53.9 | |
| 1600–3000 | 83 | 40.7 | |
| ≥3100 | 11 | 5.4 |
Note: *Non-candidates for marital status.
Total and Positive Cases of Clinical and Sample-Related Characteristics of Sterile Body Fluid Infection Among Patients at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021
| Variables | Category | Growth N (%) | No Growth N (%) | Total N (%) | |
|---|---|---|---|---|---|
| CSF | 17 (16) | 89 (84) | 106 (52.0) | ||
| Synovial | – | 3 (100) | 3 (1.5) | ||
| Pleural | 12 (19.7) | 49 (80.3) | 61 (29.8) | ||
| Peritoneal | 5 (14.7) | 29 (85.3) | 34 (16.7) | ||
| 34 (16.7) | 170 (83.3) | 204 (100) | |||
| Inpatient | 21 (22.8) | 71 (77.2) | 92(45.1) | ||
| Outpatient | 13 (11.6) | 99 (88.4) | 112 (54.9) | ||
| 34 (16.7) | 170 (83.3) | 204 (100) | |||
| Gynecology-obs | 1 (25) | 3 (75) | 4 (2.0) | ||
| Pediatrics | 11 (17.2) | 53 (82.8) | 64 (31.3) | ||
| Medical | 21 (17.4) | 100 (82.6) | 121 (59.3) | ||
| Surgical | 1 (14.3) | 6 (85.7) | 7 (3.4) | ||
| NICU | – | 3 (100) | 3 (1.5) | ||
| Isolation center | – | 5 (100) | 5 (2.5) | ||
| 34 (16.7) | 170 (83.3) | 204 (100) | |||
| Clear | 8 (8) | 92 (92) | 100 (49.0) | ||
| Turbid | 19 (26.8) | 52 (73.2) | 71 (34.8) | ||
| Bloody | 2 (13.3) | 13 (86.7) | 15 (7.4) | ||
| Other* | 5 (27.8) | 13 (72.2) | 18 (8.8) | ||
Note: *Purulent, yellowish.
Figure 1Bacterial isolates from patients diagnosed with sterile body fluid infections at HFSUH, Harar, Eastern Ethiopia at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021.
Bivariate and Multivariate Analysis of Factors Associated with Bacterial Infections from Sterile Body Fluids at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021
| Bivariant Analysis | Multivariable Analysis | ||||||
|---|---|---|---|---|---|---|---|
| Variables | Category | Culture Growth N (%) | COR (95% CI) | P-value | AOR (CI 95%) | P-value | |
| Yes | No | ||||||
| Male | 23(17.7) | 107(82.3) | 1.23(0.56, 2.69) | 0.60 | |||
| Female® | 11(15) | 63(85) | |||||
| Rural | 24(17.8) | 111(82.2) | 1.27(0.57, 2.85) | 0.55 | |||
| Urban® | 10(14.5) | 59(85.5) | |||||
| ≤20 | 11(11.5%) | 85(88.5%0 | 1.94(0.23, 16.16) | 0.54 | 2.28(0.25, 20.91) | 0.46 | |
| 41–60 | 9(25.7%) | 26(74.3%) | 5.19(0.59, 45.09) | 0.135 | 5.67(0.59, 55.31) | 0.13 | |
| ≥61 | 13(22.8%) | 44(77.2%) | 4.43(0.53, 36.80) | 0.168 | 5.62(0.61, 51.97) | 0.13 | |
| 21–40 | 1(6.3%) | 15(93.7%) | |||||
| Inpatient | 21(22.8%) | 71(77.2%) | 2.25(1.058, 4.796) | 0.035 | 3.59(1.52, 8.51) | ||
| Outpatient® | 13(11.6%) | 99(88.4%) | |||||
| Synovial | – | 3 (100) | Fisher’s exact test F-test=0.68 | P=0.89 | |||
| Plueral | 12(19.7) | 49 (80.3) | |||||
| Ascites | 5 (14.7) | 29 (85.3) | |||||
| CSF | 17(16) | 89(84) | |||||
| Turbid | 19(26.8%) | 52(73.2%) | 4.20(1.72, 10.27) | 0.002 | 4.35(1.67, 11.29) | ||
| Bloody | 2(13.3%) | 13(86.7%) | 1.77(0.34, 9.26) | 0.499 | 1.37(0.25, 7.5) | 0.714 | |
| Other | 5(27.8%) | 13(72.2%) | 4.42(1.27, 15.59) | 0.021 | 3.66(0.96, 13.9) | 0.058 | |
| Clear | 8(8%) | 92(92%) | |||||
Note: *Statistically significant.
Abbreviations: COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; ®, reference category.
Antimicrobial Susceptibility Pattern of a Gram-Negative Bacterial Isolate from Sterile Body Fluid Samples at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021
| Antimicrobial Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N = 24 | ||||||||||
| Isolated Organism | Pattern | AMP | AXC | CRO | CTZ | CPR | SXT | MEM | AMK | GN |
| S | 1 | 4 | 2 | 1 | 8 | 1 | 8 | 4 | 4 | |
| I | – | 4 | 1 | – | – | 5 | 1 | 3 | 1 | |
| R | 8 | 1 | 6 | 8 | 1 | 3 | – | 2 | 4 | |
| S | – | 2 | – | – | 7 | 1 | 6 | 7 | 1 | |
| I | – | 4 | – | – | – | 2 | – | – | – | |
| R | 7 | 1 | 7 | 7 | – | 4 | 1 | 6 | ||
| S | – | – | – | – | 1 | – | – | 2 | – | |
| I | – | – | – | – | – | – | – | – | – | |
| R | 2 | 2 | 2 | 2 | 1 | 2 | 2 | – | 2 | |
| S | – | – | – | – | 1 | – | 1 | 1 | 1 | |
| I | 1 | – | – | – | – | – | – | – | – | |
| R | – | 1 | 1 | 1 | – | 1 | – | – | – | |
| S | – | – | – | – | 1 | 1 | 1 | – | – | |
| I | 1 | 1 | 1 | 1 | – | – | – | 1 | – | |
| R | – | – | – | – | – | – | – | – | 1 | |
| S | – | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| I | – | – | – | – | – | – | – | – | – | |
| R | 1 | – | – | – | – | – | – | – | – | |
| S | – | 2 | – | – | 1 | – | 2 | 1 | ||
| I | – | – | 1 | 2 | – | 1 | – | – | – | |
| R | 2 | – | 1 | – | 1 | 1 | – | – | 1 | |
| S | – | 1 | – | 1 | 1 | – | 1 | 1 | – | |
| I | – | – | – | – | – | 1 | – | – | – | |
| R | 1 | – | 1 | – | – | – | – | – | 1 | |
| Total (24, %) | S | 1(4.2) | 10(41.7) | 3(12.5) | 3(12.5) | 21(87.5 | 4(16.7) | 20(83.3) | 18(75) | 8(33.3) |
| I | 2(8.3) | 9(37.5) | 3(12.5) | 3(12.5) | – | 9(37.5) | 1(4.2) | 4(16.7) | 1(4.2) | |
| R | 21(87.5) | 5(20.8) | 18(75) | 18(75) | 3(12.5) | 11(45.8) | 3(12.5) | 2(8.3) | 15(62.5) | |
Abbreviations: AMP, ampicillin; CRO, ceftriaxone; AMC, amoxicillin-clavulanic acid; GN, gentamicin; SXT, trimethoprim-sulfamethoxazole; CTZ, ceftazidime: MEM, meropenem; AMK, amikacin; CPR, ciprofloxacin; S, sensitive; I, intermediate; R, resistant.
Antimicrobial Susceptibility Patterns of a Gram-Positive Bacterial Isolate from Sterile Body Fluid Samples at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2021
| Antimicrobial Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 10 | Penicillins | |||||||||||
| Isolates (N) | Pattern | P | AMP | AXC | FOX | CRO | ERY | CPR | SXT | VA | GN | CLN |
| S | – | – | 3 | – | – | – | 2 | 4 | NA | – | 3 | |
| I | – | 1 | 1 | – | – | 1 | – | – | 2 | 1 | ||
| R | 4 | 3 | – | 4 | 4 | 3 | 2 | – | 2 | – | ||
| S | – | – | – | NA | – | – | – | – | – | NA | – | |
| I | – | 1 | 2 | NA | – | 1 | 1 | – | – | NA | 1 | |
| R | 4 | 3 | 2 | NA | 4 | 3 | 3 | 4 | 4 | NA | 3 | |
| S | – | 1 | 1 | 1 | 1 | 1 | 1 | – | NA | – | 1 | |
| I | 1 | – | – | – | – | – | – | 1 | NA | – | – | |
| R | – | – | – | – | – | – | – | – | NA | 1 | – | |
| S | 1 | 1 | 1 | NA | 1 | 1 | 1 | 1 | – | – | – | |
| I | – | – | – | NA | – | – | – | – | 1 | – | 1 | |
| R | – | – | – | NA | – | – | – | – | – | 1 | – | |
| Total (n = 10, %) | S | 1(10 | 2(20) | 5(50) | 1 (10) | 2(20 | 2(20 | 4(40) | 5(50) | – | – | 4(40) |
| I | 1(10 | 2(20) | 2(20) | – | – | 2(20 | 1(10) | 1(10) | 1(20 | 2(33) | 3(30) | |
| R | 8(80 | 6(60) | 2(20) | 4(90) | 8(80 | 6(60 | 5(50) | 4(40) | 4(80 | 4(67) | 3(30) | |
Abbreviations: NA, not applicable; AMP, ampicillin; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; AMC, amoxicillin-clavulanic acid GN, gentamicin; VA, vancomycin; P, penicillin; CPR, ciprofloxacin; FOX, cefoxitin; ERY, erythromycin; CLN, clindamycin; S, sensitive; I, intermediate; R, resistant.